WALD (WALD) revenue breakdown
By segment, Obagi Medical is the largest at 59% of fiscal 2025 revenue, growing 17% a year over 2 years.
By product, Net product sales is the largest at 99% of fiscal 2025 revenue, growing 32% a year over 4 years.
Revenue by segment
Fiscal years, as WALD reports them in its 10-K filings; fiscal 2025 total $272M.
| Segments | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|
| Obagi Medical | $118M | $149M | $162M | 59% |
| Milk Makeup | $100M | $125M | $110M | 41% |
Revenue by product
Fiscal years, as WALD reports them in its 10-K filings; fiscal 2025 total $272M.
| Products | 2020 | 2021 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|
| Net product sales | $89M | $137M | $213M | $269M | $268M | 99% |
| Royalty | $6M | $6M | $5M | $4M | $4M | 1% |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for WALD.
Open WALD in InvestinglyQuestions
Where does WALD make its money?
In fiscal 2025, by segment: Obagi Medical $162M, Milk Makeup $110M.
From WALD's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.